Abstract:Gene therapy has long held promise to correct a variety of human diseases and defects. Discovery of the Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), the mechanism of the CRISPR-based prokaryotic adaptive immune system (CRISPR-associated system, Cas), and its repurposing into a potent gene editing tool has revolutionized the field of molecular biology and generated excitement for new and improved gene therapies. Additionally, the simplicity and flexibility of the CRISPR/Cas9 site-specific nuclease system has led to its widespread use in many biological research areas including development of model cell lines, discovering mechanisms of disease, identifying disease targets, development of transgene animals and plants, and transcriptional modulation. In this review, we present the brief history and basic mechanisms of the CRISPR/Cas9 system and its predecessors (ZFNs and TALENs), lessons learned from past human gene therapy efforts, and recent modifications of CRISPR/Cas9 to provide functions beyond gene editing. We introduce several factors that influence CRISPR/Cas9 efficacy which must be addressed before effective in vivo human gene therapy can be realized. The focus then turns to the most difficult barrier to potential in vivo use of CRISPR/Cas9, delivery. We detail the various cargos and delivery vehicles reported for CRISPR/Cas9, including physical delivery methods (e.g. microinjection; electroporation), viral delivery methods (e.g. adeno-associated virus (AAV); full-sized adenovirus and lentivirus), and non-viral delivery methods (e.g. liposomes; polyplexes; gold particles), and discuss their relative merits. We also examine several technologies that, while not currently reported for CRISPR/Cas9 delivery, appear to have promise in this field. The therapeutic potential of CRISPR/Cas9 is vast and will only increase as the technology and its delivery improves.

Applications of CRISPR technologies in transplantation

High-throughput CRISPR technology: a novel horizon for solid organ transplantation

The use of CRISPR/Cas associated technologies for cell transplant applications

CRISPR innovations in tissue engineering and gene editing

CRISPR/Cas system: An emerging technology in stem cell research

Emerging approaches and technologies in transplantation: the potential game changers

A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery

Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery

Delivering CRISPR: a review of the challenges and approaches

The Potential Revolution of Cancer Treatment with CRISPR Technology

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling

Advance of Clustered Regularly Interspaced Short Palindromic Repeats-Cas9 System and Its Application in Crop Improvement

CRISPR‐Cas9 delivery strategies and applications: Review and update

Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect

Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation

Therapeutic applications of CRISPR/Cas9 system in gene therapy

CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool

Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies